Tuesday, 01 October 2024
A team of scientists at the 糖心原创, have uncovered how the parasite that causes malaria orchestrates their cell division – which is key in enabling the parasite to transmit this deadly disease.
In a new paper, published in , a team of scientists at the university, along with collaborators across the globe, show how they have uncovered key regulators of how malaria parasites manage their cell division.
Malaria is a major public health issue in many developing parts of the world. It is transmitted by female mosquitoes which ingest the parasites when they bite. Malaria was responsible for approximately 608,000 deaths in 2022 (WHO) and is caused by a single-celled parasite termed Plasmodium, that invades the liver and red blood cells.
This new research is led by Professor Rita Tewari from the School of Life Sciences at the university and Professor Mathieu Brochet at the University of Geneva. It aims to unravel the atypical mode of multiplication of the malaria parasite with particular focus on the developmental stages of the parasite within the mosquito in the hope of finding new therapeutic targets.
It is clear by looking at COVID-19, that controlling the transmission of parasites is equally crucial in addition to controlling the disease. Hence, to have fundamental knowledge of how the parasite succeeds to divide within the mosquito and what switches it uses will help to design intervention targets.
“One of the unusual cell divisions is seen in male sex cell formation. Recently, Professor Tewari’s team of researchers have focused on some proteins called kinases. Kinases are a family of proteins which contribute to the control of nearly all cellular processes and have already become major drug targets in the fight against cancer and other diseases. However, studies on these kinases and how they are involved in cell division in Plasmodium species are scarce.”
The group have recently characterised two kinases: ARK2 and NEK1, which they have published details of how they contribute to parasite multiplication especially during transmission stages within mosquitoes.
Professor Tewari adds: “Kinases are the best drug targets and their role in parasite transmission is important to unravel. The two studies here are a step in that direction.”
The previous study detailing more on this discovery can be found in .
The scientists involved in this study were Mohammad Zeeshan and Sarah Pashley from Professor’s Tewari’s lab at Nottingham. The First author on the paper Zeeshan said: “NEK1 is a functional protein that plays a crucial role in different stages of Plasmodium development. Our study reveals that the depletion of NEK1 protein from Plasmodium arrests its cell division and sexual development. This indicates that NEK1 could be a potential drug target, not only to stop the malaria disease but also its transmission.”
The latest study in PLOS Biology can be found . The previous study detailing more on this discovery can be found in .
Story credits
Picture caption - Prof Rita Tewari's lab, L-R:
Ryuji Yanase, Sarah Pashley, Declan Brady, Akancha Mishra, Rita Tewari and Igor Blatov
Both of these studies have been produced collaboratively with other scientists both within and outside the UK highlighting the global effort to understand this disease and the process of cell division. Such collaborations have been made with:
- Professor Mathieu Brochet, University of Geneva, Switzerland;
- Eelco Tromer, University of Groningen, the Netherlands;
- Karine Le Roch, University of California, USA;
- Iva Tolic, Ru膽er Boškovi膰 Institute, Croatia.
- David Ferguson, Sue Vaughan Oxford Brookes University, UK
- Arnab Pain, KAUST, Saudi Arabia;
- Professor Tony Holder, Francis Crick Institute London, UK;
More information is available from Professor Rita Tewari from the School of Life Sciences at rita.tewari@Nottingham.ac.uk or Charlotte Anscombe, Media Relations Manager in the Press Office at the 糖心原创, on +44 (0)115 74 84417, charlotte.anscombe@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.